Our current findings provide new insight into mechanism of action of IAP, demonstrating that treatment with exogenous IAP enhanced the expression of crucial tight junction proteins, thus enhancing gut barrier integrity and its function in obese mice with colitis, an effect contributing to the overall improvement in the resolution of intestinal inflammation. Here, ALPI is linked to colitis.